SCHEMBL30846339

SCHEMBL30846339

Cn1ncc2cccc(NS(=O)(=O)c3ccc(NN)nc3)c21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC40A1 Q9NP59 8/20 0.42
▸ GAA P10253 5/20 0.41
▸ KDM4E B2RXH2 4/20 0.41
▸ MAPT P10636 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ TDP1 Q9NUW8 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ NMT1 P30419 1/20 0.39
▸ GLO1 Q04760 3/20 0.39
▸ MITF O75030 1/20 0.39
▸ S1PR4 O95977 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ S1PR1 P21453 1/20 0.39
▸ AGTR1 P30556 1/20 0.39
▸ OPRK1 P41145 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ CKS1B P61024 1/20 0.39
▸ SKP2 Q13309 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27154161 1.00 SLC40A1 (0.42) SLC40A1GAAKDM4EMAPTKMT2A
SCHEMBL30846193 0.84 GAA (0.55) SLC40A1GAAKDM4EMAPTKMT2A
SCHEMBL27123592 0.84 GAA (0.55) SLC40A1GAAKDM4EMAPTKMT2A
SCHEMBL27117884 0.81 SLC40A1 (0.39) SLC40A1GAAMAPTKMT2ATDP1
SCHEMBL30846478 0.81 TDP1 (0.41) SLC40A1GAAMAPTKMT2ATDP1
SCHEMBL27126473 0.81 TDP1 (0.41) SLC40A1GAAMAPTKMT2ATDP1
SCHEMBL27118385 0.80 SLC40A1 (0.44) SLC40A1MAPTKMT2ATDP1MEN1
SCHEMBL30846465 0.79 SLC40A1 (0.40) SLC40A1GAAMAPTKMT2ATDP1
SCHEMBL30846276 0.79 SLC40A1 (0.40) SLC40A1GAAMAPTKMT2ATDP1
SCHEMBL30846306 0.79 SLC40A1 (0.42) SLC40A1MAPTKMT2ATDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024044344-A1 PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 — — WO disclosed
Send feedback